Simparica Trio for Cats

Simparica Trio (sarolaner + moxidectin + pyrantel) is a combination parasite preventative that is FDA‑approved for dogs only—not for cats. It prevents heartworm disease and protects against fleas, ticks, and certain intestinal worms in dogs. It is prescription-only in the U.S. (Rx). As of February 22, 2026, there is no approved “Simparica Trio for Cats.” Do not give a dog’s Simparica Trio to a cat. If a cat was exposed (chewed or swallowed a dose), contact the clinic immediately; if the cat is trembling, unsteady, or seizing, go to an emergency clinic. Your veterinarian can discuss safe, cat-specific parasite preventatives.

Important: As of February 22, 2026, there is no FDA‑approved Simparica Trio product for cats. Simparica Trio (sarolaner–moxidectin–pyrantel) is a prescription oral chew labeled for dogs only. Using a dog‑only medication in cats is not recommended and could be harmful. Common owner FAQs (short answers you can give): • “Can I give my cat my dog’s Simparica Trio?” No—please don’t. It’s a dog‑only product; your veterinarian can discuss safe, cat‑specific parasite preventives. • “What if my cat accidentally chewed/swallowed a Simparica Trio tablet?” This is urgent. Contact us, an emergency vet, or a pet poison control line immediately and have the package handy. Watch for vomiting, unsteadiness, tremors, or seizures—seek emergency care if these occur. • “What does Simparica Trio cover for cats?” There is no feline label; the listed protections apply to dogs only. Your veterinarian can recommend appropriate feline preventives for fleas, ticks, heartworm, and intestinal worms. • “Are medicines in this class safe for cats?” The isoxazoline drug class (which includes sarolaner) has, on rare occasions, been associated with neurologic effects in dogs and cats. Safety depends on using a cat‑labeled product under veterinary guidance; your veterinarian can advise what’s appropriate for your cat.

Important context: As of February 22, 2026, Simparica Trio (sarolaner–moxidectin–pyrantel) is FDA‑approved for dogs only and there is no approved feline product. When owners call about a cat, it is usually due to accidental ingestion or off‑label exposure. There is no established "normal" side‑effect profile for cats with this product. Owners may describe nonspecific signs like vomiting, diarrhea, decreased appetite, or tiredness; isoxazoline drugs (the class that includes sarolaner) have, in some pets, been associated with neurologic signs such as tremors, wobbliness/ataxia, or seizures. Your veterinarian can discuss risks and next steps for that individual cat. ([fda.gov](https://www.fda.gov/animal-veterinary/cvm-updates/fda-approves-simparica-trio-combination-drug-heartworm-and-other-parasites?utm_source=openai)) Triage guidance for calls: Because this product is not labeled for cats, any exposure should be brought to a veterinarian’s attention the same day. Escalate immediately if the owner reports tremors, wobbliness, collapse, or seizures, or if vomiting is repeated/persistent or the cat seems very weak; advise urgent evaluation while you connect them with a veterinarian or direct them to the nearest emergency clinic. For mild, single episodes of GI upset with normal behavior, arrange a same‑day veterinarian call‑back; do not provide dosing, diagnostic, or treatment advice over the phone. ([fda.gov](https://www.fda.gov/animal-veterinary/cvm-updates/fda-approves-simparica-trio-combination-drug-heartworm-and-other-parasites?utm_source=openai))

As of February 22, 2026, there is no FDA‑approved Simparica Trio (sarolaner–moxidectin–pyrantel) product for cats. Simparica Trio is a chewable tablet labeled for dogs only in the U.S. Because there is no feline‑labeled version, we cannot provide administration or compounding guidance for cats. Please verify any prescription or product packaging that lists “for cats,” and confirm with the veterinarian before any dose is given. If a client reports that their cat chewed or was given a dog Simparica Trio tablet, advise immediate contact with the veterinarian or an emergency clinic. Watch for concerning signs such as vomiting, tremors, ataxia, or seizures; if these occur, this is an emergency and the pet should be seen right away. Your veterinarian can discuss safe, cat‑labeled parasite preventives and how to administer them.

Important: There is no FDA‑approved Simparica Trio product for cats. Simparica Trio (sarolaner–moxidectin–pyrantel) is approved for dogs only. If a caller requests a “Simparica Trio refill for a cat,” verify species and do not process as a feline refill. A valid veterinarian‑client‑patient relationship (VCPR) is required for any prescription parasiticide; the veterinarian must authorize the medication and can discuss appropriate feline options. Workflow: 1) Confirm pet’s name, species, DOB/weight, owner contact, product name requested, how many doses remain, prior reactions, last exam date, and preferred pharmacy. 2) Check the record for the last approved feline parasiticide and last exam/parasite testing; route the request to the veterinarian for review. 3) Set expectations: refills are typically processed within 1–2 business days after doctor approval. 4) Online pharmacy: we can transmit the prescription to a licensed pharmacy (or our clinic’s partner pharmacy) once the veterinarian approves; unlimited refills are not allowed, and VCPR/state rules apply. Escalation: If the caller reports a cat chewed or was given a dog Simparica Trio tablet—or the cat has neurologic signs such as tremors, stumbling/ataxia, or seizures—transfer to a veterinarian immediately. If no veterinarian is available or it’s after hours, direct the client to the nearest emergency clinic without delay. Your veterinarian can discuss risks, next steps, and safe, approved feline preventatives.

As of February 22, 2026, Simparica Trio (sarolaner–moxidectin–pyrantel) is FDA‑approved for dogs only; there is no feline‑labeled Simparica Trio. If a cat was given or may have eaten a dog’s Simparica Trio, stop the call triage and get a veterinarian or technician immediately. Do not advise re‑dosing or home care—this needs clinical guidance. Emergency red flags after exposure to this combination (or any isoxazoline‑containing product) include shaking/tremors, stumbling/wobbliness, seizures, sudden extreme lethargy or collapse, dilated pupils, heavy drooling, repeated vomiting/diarrhea, trouble breathing, or facial swelling/hives. If any of these are present, treat as an emergency and arrange immediate in‑clinic evaluation or referral to the nearest ER. The veterinarian can assess product/strength ingested, timing, current meds, and the cat’s risk factors to determine next steps. Note: Isoxazoline drugs (such as sarolaner) have been associated with neurologic adverse events in some cats and dogs, and macrocyclic lactones (such as moxidectin) can cause neurologic signs with excessive exposure. Severe allergic reactions are rare but can present with rapid‑onset breathing difficulty, vomiting, collapse, or facial swelling—escalate immediately. Your veterinarian can discuss risks and what monitoring or care is appropriate.

Important: As of February 22, 2026, there is no FDA‑approved Simparica Trio product for cats in the United States; Simparica Trio (sarolaner‑moxidectin‑pyrantel) is approved for dogs only. If a client says their cat is on “Simparica Trio,” confirm the exact product name on the box/tube and hand off to a veterinarian to verify (they may mean a different feline product such as Revolution Plus). FDA reminds clinics that isoxazoline drugs (the class that includes sarolaner) can, in rare cases, be associated with neurologic signs in cats and dogs (tremors, ataxia, seizures). Your veterinarian can discuss benefits/risks for the specific product the cat is actually using. When owners mention other meds, flag the following for veterinarian review: 1) Any additional flea/tick or heartworm/deworming product (e.g., selamectin or imidacloprid‑moxidectin topicals, other isoxazolines, OTC piperazine dewormers)—to avoid duplicate therapy or known incompatibilities (piperazine should not be combined with pyrantel). 2) Azole antifungals (ketoconazole/itraconazole), macrolide antibiotics (erythromycin/clarithromycin), or cyclosporine—these can inhibit drug transport/metabolism and may raise macrocyclic lactone (moxidectin) exposure; the veterinarian should decide if any change is needed. 3) Any history of seizures or current anticonvulsant use—because isoxazoline‑containing products carry a neurologic warning; defer to the veterinarian. Common OTC issues to ask about: dog‑only permethrin/pyrethrin spot‑ons, sprays, or collars used on or near the cat (dangerous to cats); and OTC dewormers containing piperazine. If a cat has been exposed to a dog‑only permethrin product or is showing tremors, wobbliness, or seizures after a parasite dose, advise immediate emergency care and poison control contact. Your veterinarian can provide product‑specific guidance and confirm safe combinations.

Important: There is no FDA‑approved Simparica Trio for cats as of February 22, 2026. Simparica Trio (sarolaner‑moxidectin‑pyrantel) is a chewable tablet labeled for dogs only. Do not dispense to cats. If a cat owner requests “Simparica Trio,” direct them to the veterinarian to discuss appropriate feline preventives and product selection. If your clinic stocks Simparica Trio (for dogs), store it in the original carton/blister at or below 86°F (30°C). Keep tablets in their labeled packaging until time of dosing to prevent mix‑ups; flavored chews are attractive to pets, so keep out of reach of animals and children and separate from feline medications. Do not cut or break tablets unless the veterinarian specifically instructs. Each dose is individually blister‑packed; check the expiration date on the carton/blister—there is no multi‑dose container to re‑close. Disposal for unused/expired tablets: the preferred option is a drug take‑back location or mail‑back program. If that’s not available and the product is not on FDA’s flush list, mix tablets (do not crush) with an unpalatable substance (e.g., used coffee grounds or cat litter), seal in a bag/container, and place in household trash; remove personal information from labels. If any cat or child swallows a tablet, contact a veterinarian or the ASPCA Animal Poison Control Center (888‑426‑4435) immediately.

As of February 22, 2026, Simparica Trio (sarolaner–moxidectin–pyrantel) is FDA‑approved for dogs only; there is no feline‑labeled Simparica Trio product. Because it is not approved for cats, there is no manufacturer‑directed monitoring or recheck schedule for feline use. Any request to use or refill Simparica Trio for a cat should be routed to the veterinarian to discuss cat‑safe parasite preventives and appropriate follow‑up plans. If a caller reports a cat was given a dog’s Simparica Trio or a cat chewed a tablet, treat this as urgent. The isoxazoline drug class has been associated with neurologic adverse events (e.g., tremors, wobbliness/ataxia, seizures) in some dogs and cats; vomiting or lethargy may also occur. If neurologic signs are present—or if exposure was recent and the owner is concerned—advise immediate evaluation at the nearest veterinary ER and notify a veterinarian on the team for guidance.

As of February 22, 2026, there is no FDA‑approved Simparica Trio product for cats. Simparica Trio (sarolaner, moxidectin, pyrantel) is a prescription chewable approved for dogs only. For cats, your veterinarian can discuss cat‑specific parasite preventives that are safe and effective. If a caller reports that a cat was given or ingested a dog Simparica Trio tablet, treat this as urgent: advise immediate veterinary care or referral to the nearest emergency clinic. If the cat shows concerning signs such as tremors, unsteadiness, seizures, severe vomiting, or lethargy after any isoxazoline exposure, escalate to the veterinarian or emergency care right away. Phrases to avoid: “It’s safe for cats,” “Just use the dog dose,” “Skip/start this medication,” or giving any dosing advice. Instead say: “This product is for dogs only; our veterinarian can recommend a safe option for your cat.”